A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot
Clinical trial NCT01870999 · COMPLETED
Trial details
- NCT number
- NCT01870999
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-10-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.